Larger platelets are haemostatically more active and are a risk factor for developing coronary thrombosis, leading to myocardial infarction. Patients with larger platelets can easily be identified during routine haematological analysis and could possibly benefit from preventive treatment. Thus, PVI are an important, simple, effortless, and cost effective tool that should be used and explored extensively, especially in countries such as India, for predicting the possibility of impending acute events.
index (LAVI). Conclusions: By utilizing 2016 versus 2009 diastolic function criteria to a Hispanic population with T2D, the prevalence of PDD decreased from 37% to 7%, consistent with the new guidelines being more specific and less sensitive for diagnosing PDD.
It is estimated that 20-25% of sarcoidosis patients with pulmonary/systemic involvement, have asymptomatic cardiac involvement. When signs or symptoms do occur, manifestations include conduction abnormalities, ventricular arrhythmias or sudden cardiac death. We sought to determine the prevalence of conduction abnormalities, arrhythmias and implantable cardiac defibrillators (ICD) in cardiac sarcoidosis (CS) along with comorbidities throughout the United States.
METHODS:We conducted a retrospective analysis using the National Inpatient Sample (NIS-HCUP) database for all CS admissions in 2016 via the International Classification of Diseases 10 code D86.85. Codes used for arrhythmias and conduction delays included: AV block, fascicular blocks, bundle branch blocks (BBB) supraventricular tachycardia (SVT), atrial fibrillation (AF), atrial flutter (AFlut), premature ventricular contraction (PVC), SA-Node dysfunction and cardiac arrest (CA). Procedure codes for ICD placement during hospitalization used were: 02HK3KZ,
The frequency of advanced cardiopulmonary imaging has increased the incidence of diagnosis of coronary artery anomalies, but this poses an interesting management dilemma of what to do with them once these anomalies are found. We present the case of a 57-year-old female with a past medical history of postpartum cardiomyopathy, recovered heart failure with reduced ejection fraction (EF), and alcohol use disorder who presented with chest pain, shortness of breath, nausea, vomiting, and palpitations. A CT angiogram was performed to rule out pulmonary embolism. No pulmonary embolism was found; however, the CT scan revealed an anomalous right coronary artery originating from the left coronary cusp, which had a malignant interarterial course (ARCA-LCC-IA) with a right dominant pattern of myocardial circulation. Subsequent nuclear stress testing did not show evidence of ischemia. Echocardiogram revealed a recurrently reduced EF of 40%. Our patient poses a management dilemma since she presented with possible angina and was found to have an anomalous right coronary artery (ARCA) with a malignant course, but subsequently she had a negative exercise stress test with nuclear perfusion imaging. We will review the literature on ARCA-LCC-IA and its clinical manifestations both generally and with its connection to this case as well as its management. We discuss the incidence, diagnosis, and management of ARCA-LCC-IA, with a focus on incidentally found lesions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.